About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 62 record(s)
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Nothing to report this month
Organization: Elections Canada
Req # A-2019-00034
All reports, memos, emails, briefing notes and other documentation, including texts, regarding "influencers" between May 1, 2019, and June 26, 2019.Organization: Elections Canada
June 2023
Req # A-2023-00007
We are seeking median rate information for all categories of service on all streams of business for the recently awarded ECGZ-RFP-2020-0716 solicitation at Elections Canada. Please note that we are not seeking proprietary information about individual rates for each company, just the median rates calculated for all bids as outlined in the RFP. The categories on this contract are as follows: Stream 1 Business Services: Business Analyst L3 Business Architect L3 Business Consultant L3 Business Continuity/Disaster Recovery Specialist L3 Business Process Re-Engineering Consultant L3 Business System Analyst L3 Business Transformation Architect L3 Courseware Developer L3 Help Desk Specialist L3 Network Support Specialist L3 Operation Support Specialist L3 Technical Writer L3; Stream 2 PM Services: Change Management Consultant L3 Enterprise Architect L3 Project Executive L3 Project Coordinator L3 Project Leader L3 Project Manager L3 Project Scheduler L3 Quality Assurance Specialist L3 Risk Management Specialist L3; Stream 3 Application Services: Application Software Architect L3 Enterprise Resource Planning Functional Analyst L3 Enterprise Resource Planning Programmer Analyst L3 Enterprise Resource Planning System Analyst L3 Enterprise Resource Planning Technical Architect L3 Programmer Software Developer L3 Programmer Analyst L3 System Analyst L3 System Auditor L3 Tester L3 Web Architect L3 Web Designer L3 Web Developer L3 Web Graphic Designer L3 Web Multi-media Content Consultant L3 Webmaster L3; Stream 4 IM/IT Services: Data Conversion Specialist L3 Database Administrator L3 Database Analyst/Information Management Administrator L3 Database Modeller/Information Management Modeller L3 Information Management Architect L3 Network Analyst L3 Platform Analyst L3 Storage Architect L3 System Administrator L3 Technical Architect L3 Technology Architect L3Organization: Elections Canada
June 2023
Req # A-2023-00015
For the 44th general election (held on September 20, 2021), please indicate the overall election expense limits for each political party, as calculated according to the formula described in the Canada Elections Act.Organization: Elections Canada
June 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09228
All correspondence between PMPRB Board members and PMPRB staff pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson, Mélanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09229
All correspondence between the former PMPRB Acting Chairperson, Melanie Bourassa-Forcier, and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023